Abokirate

AbokiFX Rate get the live exchange rates. Convert foreign currencies instantly with the Abokifx calculator. Nigeria News..,

Vladimir Putin, Russian President

Russia COVID-19 vaccine;Experts recommend for people between 18 and 60 years

Russia’s COVID-19 vaccine is recommended for use by individuals between the ages of 18 and 60, an official of the Russian Health Ministry has declared.

The Head of the Russian Health Ministry’s Scientific Centre for Expert Evaluation of Medicinal Products, Vladimir Bondarev, disclosed this at a news conference on Wednesday in Moscow.

Bondarev added that more research still needs to be done to formulate a vaccine for people over 60 years old. He noted that it would be probably done during post-registration clinical trials.

CHECK THIS OUT! Worshippers cannot contract COVID-19 in church – Anglican bishop

Earlier this week, Russia announced its registration of the world’s first coronavirus vaccine, named `Sputnik V’, and intended for industrial production.

This was after President Vladimir Putin had endorsed the vaccine, saying it had passed all necessary checks.

“In Russia, it is customary to certify [vaccines for] children from birth to 18 years old; adults from 18 years to 60 years old; and older people — over 60 years old.

“Clinical studies have now been carried out on a group of volunteers aged from 18 years to 60 years old. Thus, this vaccine is now indicated for use in people from 18 years to 60 years old,” Mr Bondarev said.

VISIT ABOKIFX RATE FOR LIVE RATES OF DOLLAR TO NAIRA

Meanwhile, the Director of the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, one of the entities that helped create the vaccine, Alexander Gintsburg, has declared that he has also been vaccinated. The Gamaleya Research Institute worked in collaboration with the Russian Direct Investment Fund to formulate the vaccine.

Mr Gintsburg, who is in his late 60s, said he felt good after the vaccination.

YOU MIGHT ALSO LIKE, DSS invites Mailafia for questioning for accusing gov of sponsoring Boko Haram

The vaccine, which has two separately injected components, is expected to build sustainable immunity against the virus.

It has so far been tested on 76 volunteers separately at two institutions — the Moscow-based Sechenov University and the Defence Ministry’s Burdenko Main Military Clinical Hospital.